83.94
-0.43 (-0.51%)
| Penutupan Terdahulu | 84.37 |
| Buka | 83.52 |
| Jumlah Dagangan | 1,234,151 |
| Purata Dagangan (3B) | 5,108,354 |
| Modal Pasaran | 48,332,652,544 |
| Harga / Pendapatan (P/E TTM) | 45.37 |
| Harga / Pendapatan (P/E Ke hadapan) | 28.49 |
| Harga / Jualan (P/S) | 7.94 |
| Harga / Buku (P/B) | 4.78 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 23 Jul 2026 |
| Margin Keuntungan | 75.71% |
| Margin Operasi (TTM) | 29.01% |
| EPS Cair (TTM) | 2.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 6.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 1.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.86% |
| Nisbah Semasa (MRQ) | 4.45 |
| Aliran Tunai Operasi (OCF TTM) | 876.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.45 B |
| Pulangan Atas Aset (ROA TTM) | 8.42% |
| Pulangan Atas Ekuiti (ROE TTM) | 16.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Edwards Lifesciences Corporatio | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | 2.0 |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.75 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.91% |
| % Dimiliki oleh Institusi | 89.29% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |